CRISPR Therapeutics AG (CRSP) EBT Margin Growth (3y) (2019 - 2026)
CRISPR Therapeutics AG (CRSP) EBT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | -832,219.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -832,219.00 |
| Dec 31, 2025 | 198.20 Mn |
| Sep 30, 2025 | 17.44 Mn |
| Jun 30, 2025 | 9.05 Mn |
| Mar 31, 2025 | 308,794.00 |
| Dec 31, 2024 | 214,157.00 |
| Sep 30, 2024 | 137,283.00 |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | -210,117.00 |
| Dec 31, 2023 | 3.11 Mn |
| Jun 30, 2023 | 18.01 Mn |
| Mar 31, 2023 | 4.41 Mn |
| Dec 31, 2022 | -200.09 Mn |
| Sep 30, 2022 | -18.64 Mn |
| Jun 30, 2022 | -9.69 Mn |
| Mar 31, 2022 | -394,919.00 |
| Dec 31, 2021 | 4.01 Mn |
| Sep 30, 2021 | -652,045.00 |
| Jun 30, 2021 | 360,350.00 |
| Mar 31, 2021 | -1.88 Mn |